Correlation Between Dice Molecules and DiaMedica Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Dice Molecules and DiaMedica Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dice Molecules and DiaMedica Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dice Molecules Holdings and DiaMedica Therapeutics, you can compare the effects of market volatilities on Dice Molecules and DiaMedica Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dice Molecules with a short position of DiaMedica Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dice Molecules and DiaMedica Therapeutics.

Diversification Opportunities for Dice Molecules and DiaMedica Therapeutics

0.43
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Dice and DiaMedica is 0.43. Overlapping area represents the amount of risk that can be diversified away by holding Dice Molecules Holdings and DiaMedica Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on DiaMedica Therapeutics and Dice Molecules is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dice Molecules Holdings are associated (or correlated) with DiaMedica Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of DiaMedica Therapeutics has no effect on the direction of Dice Molecules i.e., Dice Molecules and DiaMedica Therapeutics go up and down completely randomly.

Pair Corralation between Dice Molecules and DiaMedica Therapeutics

If you would invest  423.00  in DiaMedica Therapeutics on September 12, 2024 and sell it today you would earn a total of  120.00  from holding DiaMedica Therapeutics or generate 28.37% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy4.55%
ValuesDaily Returns

Dice Molecules Holdings  vs.  DiaMedica Therapeutics

 Performance 
       Timeline  
Dice Molecules Holdings 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Dice Molecules Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound fundamental indicators, Dice Molecules is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.
DiaMedica Therapeutics 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in DiaMedica Therapeutics are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain basic indicators, DiaMedica Therapeutics exhibited solid returns over the last few months and may actually be approaching a breakup point.

Dice Molecules and DiaMedica Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Dice Molecules and DiaMedica Therapeutics

The main advantage of trading using opposite Dice Molecules and DiaMedica Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dice Molecules position performs unexpectedly, DiaMedica Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DiaMedica Therapeutics will offset losses from the drop in DiaMedica Therapeutics' long position.
The idea behind Dice Molecules Holdings and DiaMedica Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

Other Complementary Tools

Commodity Directory
Find actively traded commodities issued by global exchanges
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Stocks Directory
Find actively traded stocks across global markets
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine